Fixed-Life or Rechargeable Battery for Deep Brain Stimulation: Preference and Satisfaction in Chinese Patients With Parkinson's Disease

Abstract

Introduction: DBS is a widely used therapy for PD. There is now a choice between fixed-life implantable pulse generators (IPGs) and rechargeable IPGs, each having advantages and disadvantages. This study aimed to evaluate the preference and satisfaction of Chinese patients with Parkinson's disease (PD) who were treated with deep brain stimulation (DBS).Materials and Methods: Two hundred and twenty PD patients were treated with DBS and completed a self-reported questionnaire to assess their long-term satisfaction and experience with the type of battery they had chosen and the key factors affecting these choices. The survey was performed online and double-checked for completeness and accuracy.Results: The median value of the postoperative duration was 18 months. The most popular way for patients to learn about DBS surgery was through media (79/220, 35.9%) including the Internet and television programs. In total, 87.3% of the DBS used rechargeable IPGs (r-IPG). The choice between rechargeable and non-rechargeable IPGs was significantly associated with affordability (χ(1)2 = 19.13, p < 0.001). Interestingly, the feature of remote programming significantly affected patients' choices between domestic and imported brands (χ(1)2 = 16.81, p < 0.001). 87.7% of the patients were satisfied with the stimulating effects as well as the implanted device itself. 40.6% of the patients with r-IPGs felt confident handling devices within 1 week after discharge. More than half of the patients checked their batteries every week. The mean interval for battery recharge was 4.3 days. 57.8% of the patients spent around 1 h recharging, and 71.4% of them recharged the battery independently.Conclusions: Most patients were satisfied with their choice of IPGs. The patients' economic status and the remote programming function of the device were the two most critical factors in their decision. The skill of recharging the IPG was easy to master for most patients.

Movement disorder Deep brain stimulation Hybridization: Patient and caregiver outcomes

“…The frequency of recharging varies from daily to once weekly, based on the indication for DBS and the stimulation parameters [1] , [2] , [8] , [16] , [26] . Several DBS series show that patients also favored the rechargeable variants based on durability and cost, but few evaluate the role of the caregiver [2] , [11] , [24] , [26] , [27] .…”

Can Continuous Levodopa Delivery Be Achieved in the Absence of Intrajejunal Levodopa Infusion? Implications for India and Underserved Countries

“…Of note, strategies aimed at reducing DBS costs and the utilization of alternative, more affordable surgical therapies can contribute to optimizing the management of patients in need of continuous treatment. For instance, the cost‐effectiveness of non‐rechargeable implantable pulse generators in comparison to rechargeable counterparts may facilitate the dissemination of DBS within low‐income regions 66 . Moreover, although there is a preference for DBS and newer techniques like magnetic resonance imaging‐guided focused ultrasound in higher‐income nations, other ablative surgical techniques, such as radiofrequency thermoablation, and stereotactic radiosurgery, should be considered in situations where patients need to self‐finance, as often occurs in lower‐middle‐income countries.…”

A qualitative study of the symptom management in patients with chemotherapy-induced hand-foot syndrome

“…Independently obtain disease knowledge HFS patients acquire related knowledge via websites, physicians, and among patients [44,45].…”